Timed Intubation after Rocuronium for Endotracheal Intubation
Trial Summary
What is the purpose of this trial?
The purpose of this research is to learn about the difference in the endotracheal intubation condition (ease of using a device to view vocal cords, position of vocal cords, and patient's reaction to endotracheal tube insertion) and determining the appropriate time to perform the intubation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the drug Rocuronium for endotracheal intubation?
Research shows that Rocuronium provides good to excellent conditions for intubation within 45 to 60 seconds after anesthesia induction, making it a useful option for endotracheal intubation. It is faster than other muscle relaxants like vecuronium and atracurium, and while not as fast as succinylcholine, it is a suitable alternative when succinylcholine cannot be used.12345
Is rocuronium safe for use in humans?
Rocuronium is generally considered safe for use in humans as it is a muscle relaxant that does not release histamine, which can cause allergic reactions. It is used to facilitate endotracheal intubation (inserting a tube into the windpipe) and has been studied for its effects on muscle relaxation and timing for safe intubation.56789
How does the drug rocuronium differ from other drugs for endotracheal intubation?
Rocuronium, when used with the 'timing principle', provides good to excellent intubating conditions quickly, within 45 to 60 seconds after anesthesia induction, making it a fast-acting alternative to succinylcholine, especially when the latter is not suitable. Unlike succinylcholine, rocuronium is a nondepolarizing muscle relaxant, which means it works differently by blocking nerve signals to muscles without causing initial muscle contractions.1251011
Research Team
J. Ross Renew, MD
Principal Investigator
Mayo Clinic
Eligibility Criteria
This trial is for patients needing elective surgery where muscle relaxants like rocuronium are used. Participants must be willing to give informed consent. It's not for those with severe kidney or liver disease, surgeries involving the arm in a sterile field, rapid sequence induction cases, wrist injuries, or neuromuscular conditions like myasthenia gravis.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo endotracheal intubation under different neuromuscular blockade conditions
Follow-up
Participants are monitored for safety and effectiveness after intubation
Treatment Details
Interventions
- Endotracheal Intubation
- Rocuronium
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor